Long COVID research in minority ethnic populations may be lost in translation

Kamlesh Khunti,Amitava Banerjee,Rachael A. Evans,Melanie Calvert

DOI: https://doi.org/10.1038/s41591-024-03070-y

IF: 82.9

2024-06-26

Nature Medicine

Abstract:SARS-CoV-2 infection can lead to multiorgan systemic damage and prolonged symptoms over many weeks and months, a condition known as long COVID or post-COVID syndrome or condition. Certain populations, such as older people, those with chronic comorbidities and severe infections, socioeconomically deprived populations, and minority ethnic populations, have been disproportionately affected by acute COVID-19. A plethora of studies into long COVID have been published over the past three years, including several systematic reviews. However, data on long COVID in minority ethnic groups and across intersectional analysis are lacking. Where data have been reported, inconsistent estimates for the prevalence of long COVID have been reported. Furthermore, most published data are from high-income countries, that either fail to report demographic information or are not representative of the general population. Data from low-income countries for comparison of long COVID rates and symptoms are lacking. One large UK analysis of ten longitudinal studies reported that overall odds of long COVID symptoms lasting more than four weeks was significantly lower in south Asian and Black populations compared to white populations 1 . By contrast, a large Danish nationwide cohort study using routine data suggested that people from minority ethnic groups from North Africa, Middle East, Eastern Europe and Asia had significantly greater risk of long COVID compared to 'native Danes' (participants originating and/or born in Denmark) 2 .

biochemistry & molecular biology,cell biology,medicine, research & experimental